Treatment of Rocky Mountain spotted fever in children

Annals of Pharmacotherapy

Volumn 31, Issue 4, 1997, Pages 492-494

  Cale, Dorinda F ^a   McCarthy, Michelle W ^a  

^a SAMFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CHLORAMPHENICOL DERIVATIVE; DOXYCYCLINE; TETRACYCLINE;

APLASTIC ANEMIA; ARTICLE; BLOOD DYSCRASIA; DRUG FORMULATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RICKETTSIA RICKETTSII; ROCKY MOUNTAIN SPOTTED FEVER; TOOTH DISEASE;

EID: 0030956360     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703100418     Document Type: Article

References (23)

1. Spach DH, Liles WC, Campbell GL, Quick RE, Anderson DE, Pritsche TR. Tick-borne diseases in the United States. N Engl J Med 1993;329: 936-47.
2. Jantausch JA. Lyme disease, Rocky Mountain spotted-fever, ehrlichiosis: emerging and established challenges for the clinician. Ann Allergy 1994;73:4-11.
3. Dalton MJ, Clarke MJ, Holman RC, Krebs JW, Fishbein DB, Olson JG, et al. National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg 1995;52:405-13.
4. Saah AJ. Rickettsiosis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, Inc., 1995;1719-27.
5. Walker DH. Rocky Mountain spotted fever: a seasonal alert. Clin Infect Dis 1995;20:1111-7.
6. Abramson JS, Givner LB. Rickettsial diseases. In: Kaplan SL, ed. Current therapy in pediatric infectious disease. 3rd ed. St. Louis: MosbyYear Book, Inc., 1993:241-2.
7. Kirkland KB, Wilkinson WE, Sexton DJ. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin Infect Dis 1995;20:1118-21.
8. Dumler JS. Laboratory diagnosis of human rickettsial and ehrlichial infections. Clin Microbiol News 1996;18:57-61.
9. Walker DH, Burday MS, Folds JD. Laboratory diagnosis of Rocky Mountain spotted fever. South Med J 1980;73:1443-6.
10. Hechemy KE, Stevens RW, Sasowski S, Michaelson EE, Casper EA, Philip RN. Discrepancies in Weil-Felix and microimmunofluorescence test results for Rocky Mountain spotted fever. J Clin Microbiol 1979;9:292-3.
11. Rieder MJ. Chloramphenicol. In: Koren G, Prober CG, Gold R, eds. Antimicrobial therapy in infants and children. New York: Marcel Dekker, Inc., 1988:311-38.
12. Chloramphenicol. In: McEvoy GK, ed. AHFS 96 drug information. Bethesda, MD: American Society of Health-System Pharmacists, Inc., 1996:213-7.
13. Nahata MC. Chloramphenicol. In: Evans WE, Schentag JJ, Jusko WJ, eds. Applied pharmacokinetics: principles of therapeutic drug monitoring, 3rd ed. Vancouver, WA: Applied Therapeutics, Inc., 1992:1-16-1-24.
14. Glazko AJ, Carnes HE, Karenko A, Wolf LM, Reunter TF. Succinic acid esters of Chloramphenicol. In: Welch H, Marti-Ibanez F, eds. Antibiotics annual 1957-1958. New York: Medical Encyclopedia, Inc., 1958:792-801.
15. Committee on Infectious Diseases American Academy of Pediatrics. Rocky Mountain spotted fever. 23rd ed. Elk Grove Village, IL: American Academy of Pediatrics, 1994.
16. Abramson JS, Givner LB. Should tetracycline be contraindicated for therapy of presumed Rocky Mountain spotted fever in children less than 9 years of age (editorial)? Pediatrics 1990;86:123-4.
17. Stewart DJ. Prevalence of tetracycline in children's teeth - Study II: a resurvey after five years. BMJ 1973;3:320-2.
18. Grossman ER, Walchek A, Freedman H, Flanagan C. Tetracyclines and permanent teeth: the relation between dose and tooth color. Pediatrics 1971;47:567-70.
19. Schach von Wittenau M. Some pharmacokinetic aspects of doxycycline metabolism in man. Chemotherapy 1968;13(suppl):41-50.
20. Forti G, Benincori C. Doxycycline and the teeth (letter). Lancet 1969;1:782.
21. Yagupsky P, Gross EM, Alkan M, Bearman JE. Comparison of two dosage schedules of doxycycline in children with rickettsial spotted fever. J Infect Dis 1987;155:1215-9.
22. Beitran RR, Herrero Herrero JI. Evaluation of ciprofloxacin and doxycycline in the treatment of Mediterranean spotted fever. Eur J Clin Microbiol Infect Dis 1992;11:427-31.
23. Schaad UB, Salam MA, Aujard Y, Dagan R, Green SD, Peltola H, et al. Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission. Pediatr Infect Dis J 1995;14:1-9.